These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 22005066

  • 1. Antipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacin.
    Pallecchi L, Riccobono E, Montagnani F, Di Maggio T, Mantengoli E, Pollini S, Rossolini GM.
    J Chemother; 2011 Oct; 23(5):308-9. PubMed ID: 22005066
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia.
    Balkhy HH, Memish ZA, Shibl A, Elbashier A, Osoba A.
    East Mediterr Health J; 2005 Oct; 11(1-2):36-44. PubMed ID: 16532669
    [Abstract] [Full Text] [Related]

  • 4. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
    Fuller JD, Low DE.
    Clin Infect Dis; 2005 Jul 01; 41(1):118-21. PubMed ID: 15937772
    [Abstract] [Full Text] [Related]

  • 5. Levofloxacin, a broad spectrum anti-infective: from Streptococcus pneumoniae to Pseudomonas aeruginosa.
    Schito AM, Schito GC.
    J Chemother; 2004 Apr 01; 16 Suppl 2():3-7. PubMed ID: 15255554
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vivo development of high-level fluoroquinolone resistance in Streptococcus pneumoniae in chronic obstructive pulmonary disease.
    Pérez-Trallero E, Marimón JM, González A, Ercibengoa M, Larruskain J.
    Clin Infect Dis; 2005 Aug 15; 41(4):560-4. PubMed ID: 16028169
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005.
    Ip M, Chau SS, Chi F, Cheuk ES, Ma H, Lai RW, Chan PK.
    Antimicrob Agents Chemother; 2007 Jun 15; 51(6):2192-4. PubMed ID: 17371818
    [Abstract] [Full Text] [Related]

  • 11. Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin.
    Pfaller MA, Jones RN.
    Diagn Microbiol Infect Dis; 1997 Nov 15; 29(3):199-201. PubMed ID: 9401813
    [Abstract] [Full Text] [Related]

  • 12. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
    Louie A, Brown DL, Liu W, Kulawy RW, Deziel MR, Drusano GL.
    Antimicrob Agents Chemother; 2007 Nov 15; 51(11):3988-4000. PubMed ID: 17846144
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility of Streptococcus pneumoniae clinical isolates to quinolones.
    Tascini C, Leonildi A, Ciullo I, Flammini S, Tagliaferri E, Menichetti F.
    J Chemother; 2012 Jun 15; 24(3):185-6. PubMed ID: 22759766
    [No Abstract] [Full Text] [Related]

  • 14. Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases.
    Naba MR, Araj GF, Baban TA, Tabbarah ZA, Awar GN, Kanj SS.
    J Infect Public Health; 2010 Jun 15; 3(3):113-7. PubMed ID: 20869671
    [Abstract] [Full Text] [Related]

  • 15. Pharmacodynamics of levofloxacin against characterized ciprofloxacin-resistant Streptococcus pneumoniae.
    Lister PD.
    Postgrad Med; 2008 Sep 15; 120(3 Suppl 1):46-52. PubMed ID: 18931471
    [Abstract] [Full Text] [Related]

  • 16. Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan.
    Hsieh YC, Chang LY, Huang YC, Lin HC, Huang LM, Hsueh PR.
    Clin Microbiol Infect; 2010 Jul 15; 16(7):973-8. PubMed ID: 19778298
    [Abstract] [Full Text] [Related]

  • 17. Quinolone resistance among pneumococci: therapeutic and diagnostic implications.
    Low DE.
    Clin Infect Dis; 2004 May 15; 38 Suppl 4():S357-62. PubMed ID: 15127370
    [Abstract] [Full Text] [Related]

  • 18. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
    Deshpande LM, Sader HS, Debbia E, Nicoletti G, Fadda G, Jones RN, SENTRY Antimicrobial Surveillance Program (2001-2004).
    Diagn Microbiol Infect Dis; 2006 Mar 15; 54(3):157-64. PubMed ID: 16423493
    [Abstract] [Full Text] [Related]

  • 19. Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones.
    Huelves L, Sevillano D, Martínez-Marín C, López-Casla MT, Gracia M, Alou L, del Carmen Ponte M, Prieto J, Soriano F, Spanish Pneumococcal Infection Study Network (G03/103).
    Int J Antimicrob Agents; 2006 Apr 15; 27(4):294-9. PubMed ID: 16527462
    [Abstract] [Full Text] [Related]

  • 20. Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.
    White RL, Enzweiler KA, Friedrich LV, Wagner D, Hoban D, Bosso JA.
    Diagn Microbiol Infect Dis; 2002 Jul 15; 43(3):207-17. PubMed ID: 12106954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.